127 related articles for article (PubMed ID: 2204331)
21. Fluorine 18-labeled fluorodeoxyglucose positron emission tomography in familial Creutzfeldt-Jakob disease.
Renard D; Collombier L; Castelnovo G; Remy A; Laplanche JL; Labauge P
Arch Neurol; 2008 Oct; 65(10):1390-1. PubMed ID: 18852360
[No Abstract] [Full Text] [Related]
22. Single-photon emission computed tomography image of benzodiazepine receptors in a patient with Creutzfeldt-Jakob disease.
Itoh Y; Amano T; Shimizu T; Hashimoto J; Kubo A; Fukuuchi Y
Intern Med; 1998 Oct; 37(10):896-900. PubMed ID: 9840717
[TBL] [Abstract][Full Text] [Related]
23. A longitudinal
Chu M; Chen Z; Nie B; Liu L; Xie K; Cui Y; Chen K; Rosa-Neto P; Wu L
J Neurol; 2022 Nov; 269(11):6094-6103. PubMed ID: 35864212
[TBL] [Abstract][Full Text] [Related]
24. Iodine-123 HIPDM brain imaging findings in subacute spongiform encephalopathy (Creutzfeldt-Jakob disease).
Shih WJ; Markesbery WR; Clark DB; Goldstein S; Domstad PA; Coupal JJ; Kung H; DeKosky ST; DeLand FH
J Nucl Med; 1987 Sep; 28(9):1484-7. PubMed ID: 3305807
[TBL] [Abstract][Full Text] [Related]
25. Two sequential Tc-99m ECD SPECT studies in a case of sporadic Creutzfeldt-Jakob disease confirmed at autopsy.
Paghera B; Caobelli F; Nisa L; Puta E; Borroni B; Premi E; Padovani A; Giubbini R
Clin Nucl Med; 2011 Aug; 36(8):669-71. PubMed ID: 21716018
[TBL] [Abstract][Full Text] [Related]
26. Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) Correlation of Histopathology and MRI in Prion Disease.
Mente KP; O'Donnell JK; Jones SE; Cohen ML; Thompson NR; Bizzi A; Gambetti P; Safar JG; Appleby BS
Alzheimer Dis Assoc Disord; 2017; 31(1):1-7. PubMed ID: 28121634
[TBL] [Abstract][Full Text] [Related]
27. Decreased regional cerebral blood flow in the bilateral thalami and medulla oblongata determined by an easy Z-score (eZIS) analysis of (99m)Tc-ECD-SPECT images in a case of MM2-thalamic-type sporadic Creutzfeldt-Jakob disease.
Hayashi Y; Iwasaki Y; Yoshikura N; Asano T; Hatano T; Tatsumi S; Satoh K; Kimura A; Kitamoto T; Yoshida M; Inuzuka T
J Neurol Sci; 2015 Nov; 358(1-2):447-52. PubMed ID: 26421831
[TBL] [Abstract][Full Text] [Related]
28. FDG-PET in Creutzfeldt-Jakob disease: Analysis of clinical-PET correlation.
Renard D; Castelnovo G; Collombier L; Thouvenot E; Boudousq V
Prion; 2017 Nov; 11(6):440-453. PubMed ID: 29099286
[TBL] [Abstract][Full Text] [Related]
29. Neuropathological findings in new variant CJD and experimental transmission of BSE.
Ironside JW
FEMS Immunol Med Microbiol; 1998 Jun; 21(2):91-5. PubMed ID: 9684997
[TBL] [Abstract][Full Text] [Related]
30. Creutzfeldt-Jakob disease: a case with extensive white matter degeneration and optic atrophy.
Kitagawa Y; Gotoh F; Koto A; Ebihara S; Okayasu H; Ishii T; Matsuyama H
J Neurol; 1983; 229(2):97-101. PubMed ID: 6191005
[TBL] [Abstract][Full Text] [Related]
31. Creutzfeldt-Jakob disease in recipients of human growth hormone in the United Kingdom: a clinical and radiographic study.
Markus HS; Duchen LW; Parkin EM; Kurtz AB; Jacobs HS; Costa DC; Harrison MJ
Q J Med; 1992 Jan; 82(297):43-51. PubMed ID: 1438667
[TBL] [Abstract][Full Text] [Related]
32. 18F-FDG PET/CT in Sporadic Creutzfeldt-Jakob Disease.
Zizi G; Berger H; Lalire P; Dejust S; Morland D
Clin Nucl Med; 2020 Jul; 45(7):538-539. PubMed ID: 32433176
[TBL] [Abstract][Full Text] [Related]
33. Early detection of familial Creutzfeldt-Jakob disease on diffusion-weighted imaging before symptom onset.
Terasawa Y; Fujita K; Izumi Y; Kaji R
J Neurol Sci; 2012 Aug; 319(1-2):130-2. PubMed ID: 22640903
[TBL] [Abstract][Full Text] [Related]
34. An autopsied case of MM1-type sporadic Creutzfeldt-Jakob disease with pathology of Wernicke encephalopathy.
Iwasaki Y; Hashimoto R; Saito Y; Aiba I; Inukai A; Akagi A; Mimuro M; Miyahara H; Kitamoto T; Yoshida M
Prion; 2019 Jan; 13(1):13-20. PubMed ID: 30409087
[TBL] [Abstract][Full Text] [Related]
35. [Topodiagnosis of Creutzfeldt-Jakob disease using HMPAO-SPECT].
Heye N; Farahati J; Heinz A; Büttner T; Przuntek H; Reiners C
Nuklearmedizin; 1993 Feb; 32(1):57-9. PubMed ID: 8464762
[TBL] [Abstract][Full Text] [Related]
36. Concomitant Creutzfeldt-Jakob and Alzheimer diseases.
Powers JM; Liu Y; Hair LS; Kascsack RJ; Lewis LD; Levy LA
Acta Neuropathol; 1991; 83(1):95-8. PubMed ID: 1792870
[TBL] [Abstract][Full Text] [Related]
37. [Computed tomography of Creutzfeldt-Jakob disease].
Yagishita A
Rinsho Hoshasen; 1989 Oct; 34(11):1317-25. PubMed ID: 2689724
[TBL] [Abstract][Full Text] [Related]
38. Heidenhain variant of Creutzfeldt-Jakob disease: diffusion-weighted MRI and PET characteristics.
Tsuji Y; Kanamori H; Murakami G; Yokode M; Mezaki T; Doh-ura K; Taniguchi K; Matsubayashi K; Fukuyama H; Kita T; Tanaka M
J Neuroimaging; 2004 Jan; 14(1):63-6. PubMed ID: 14748211
[TBL] [Abstract][Full Text] [Related]
39. Visual art therapy in sporadic Creutzfeldt-Jakob disease: a case study.
Shrestha R; Trauger-Querry B; Loughrin A; Appleby BS
Neurocase; 2016; 22(2):243-7. PubMed ID: 26782687
[TBL] [Abstract][Full Text] [Related]
40. Hemisensory deficit in a patient with Creutzfeldt-Jakob disease.
Kothbauer-Margreiter I; Baumgartner RW; Bassetti C; Mathis J
Eur Neurol; 1996; 36(2):108-9. PubMed ID: 8654480
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
